|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 85, 96-99, Copyright © 1984 by American College of Chest Physicians
ARTICLES |
MM Brentani, CR Carvalho, PH Saldiva, MM Pacheco and CT Oshima
As an initial step in investigating the role of steroid hormones in lymphangiomyomatosis, the cytosolic receptors for steroid hormones were determined by a dextran charcoal method. Specific saturable receptors were found for estrogens (measured with [3H] estradiol +/- unlabeled diethylstilbestrol), progestins (measured with [3H] R5020 +/- unlabeled R5020), and glucocorticoids (measured with [3H] dexamethasone +/- unlabeled dexamethasone); they were absent for androgens (measured with [3H] R1881 +/- unlabeled R1881). Even though receptor levels were of low absolute value, they were significant because specimens of normal lung display no receptor at all. Steroid hormones may have direct effects on pulmonary lymphangiomyomatosis tissue mediated by specific receptors.
This article has been cited by other articles:
![]() |
J. Yu, A. Astrinidis, S. Howard, and E. P. Henske Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L694 - L700. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhe, Y. Yang, S. Jakkaraju, and L. Schuger Tissue Inhibitor of Metalloproteinase-3 Downregulation in Lymphangioleiomyomatosis: Potential Consequence of Abnormal Serum Response Factor Expression Am. J. Respir. Cell Mol. Biol., April 1, 2003; 28(4): 504 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Dweik, D. Laskowski, M. Özkan, C. Farver, and S. C. Erzurum High Levels of Exhaled Nitric Oxide (NO) and NO Synthase III Expression in Lesional Smooth Muscle in Lymphangioleiomyomatosis Am. J. Respir. Cell Mol. Biol., April 1, 2001; 24(4): 414 - 418. [Abstract] [Full Text] |
||||
![]() |
S R Johnson and A E Tattersfield Clinical experience of lymphangioleiomyomatosis in the UK Thorax, December 1, 2000; 55(12): 1052 - 1057. [Abstract] [Full Text] |
||||
![]() |
K. MATSUI, K. TAKEDA, Z.-X. YU, J. VALENCIA, W. D. TRAVIS, J. MOSS, and V. J. FERRANS Downregulation of Estrogen and Progesterone Receptors in the Abnormal Smooth Muscle Cells in Pulmonary Lymphangioleiomyomatosis Following Therapy . An Immunohistochemical Study Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 1002 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Logginidou, X. Ao, I. Russo, and E. P. Henske Frequent Estrogen and Progesterone Receptor Immunoreactivity in Renal Angiomyolipomas From Women With Pulmonary Lymphangioleiomyomatosis* Chest, January 1, 2000; 117(1): 25 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Johnson Rare diseases bullet 1: Lymphangioleiomyomatosis: clinical features, management and basic mechanisms Thorax, March 1, 1999; 54(3): 254 - 264. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |